NICOLE BENNETT: Open Payments
NPI 1407626658 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,419 in 77 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,629 · 2025 $1,419
Food & beverage: $1,317Education: $101
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $340 |
| Teva Pharmaceuticals USA, Inc. | 15 | $299 |
| Vanda Pharmaceuticals Inc. | 12 | $195 |
| Neurocrine BioSciences, Inc. | 6 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $146 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| ABBVIE INC. | 4 | $70 |
| Alkermes, Inc. | 3 | $53 |
| Lundbeck LLC | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: COBENFY, UZEDY, FANAPT, INGREZZA, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, ARISTADA.
Industry payments across TX — which companies pay providers there.
